BioNTech says vaccine ‘neutralises’ key mutation in UK, SA variants

Tests carried out have shown that “antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralise SARS-CoV-2 with a key mutation that is also found in two highly transmissible variants,” the company said.

Read the full story: Read More